BIOTRICITY INC. — Earnings

Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR

Next earnings (estimated): Wed, April 1, 2026 33 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)

Recent earnings · last 8 quarters

Quarter endRevenueYoYNet IncomeYoYOp. Margin
2025-12-31$4M↑+10.2%$-717K↑+41.7%11.1%
2025-09-30$4M↑+18.9%$-691K↑+55.8%7.0%
2025-06-30$4M↑+21.0%$-672K↑+81.8%7.3%
2025-03-31$4M↑+16.5%
2024-12-31$4M↑+21.7%$-1M↑+56.2%-4.7%
2024-09-30$3M↑+13.0%$-2M↑+57.7%-9.4%
2024-06-30$3M↑+6.0%$-4M↓-8.3%-34.9%
2024-03-31$3M↑+15.9%

Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.

Last earnings · FY2025 (Q4)

Revenue
$4M
↑+10.2% +$369K YoY

Earnings surprise · last 8 quarters

YoY % change · proxy for analyst surprise until estimates land

EPS history · last 10 fiscal years

diluted, GAAP, annual

Note: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.

Margin trends · 51 quarters

margin trajectory tells the operating-leverage story
Gross Margin↑+5.2pts
81.5%
Operating Margin↑+15.7pts
11.1%
Net Margin↑+16.0pts
-18.0%

Go deeper